Issue 14: February 20 2016 – Read the complete newsletter here.
This issue focuses on the major recent and upcoming biotechnology events we attend and includes a new article published about our stock opportunity as well as a Q&A with our Senior Research Scientist, Dr. Milla Zakharova.
FEATURED IN THIS ISSUE:
LATTICE IN THE NEWS: (click here for the article) “Lattice Biologics (TSXV-LBL) building on biotech success one block at a time” Columnist Gaalen Engen dives into the technology and strategy behind the company that are getting Lattice noticed as a solid investment opportunity and reveals “The company’s next generation proprietary patented Extracellular Matrix (ECM) solutions are set to revolutionize the regenerative medicine space.”
MEET THE TEAM: (click here to read her Q&A) Milla Zakharova, Ph.D. Get to know one of our newest team members, Dr. Milla Zakharova, Senior Research Scientist in this issue’s “Get to Know the Team Behind the Technology” feature. Dr. Zakharova has authored over 20 research articles published in major peer-reviewed journals (mostly as a first author). Her publications are listed in MEDLINE global bibliographical database) and have been cited by other researchers more than 200 times.
WSCS 2015: The Lattice team recently attended the World Stem Cell Summit in Atlanta, GA with over 1,200 fellow attendees including industry leaders, scientists, policymakers, and investors from 45+ countries. (Click here for our official report)
NASS 2016 Evidence & Technology Spine Summit: Join us next week in Park City, UT for the Spine event of the season.
Click Subscribe to receive updates.
Media Contact: Melanie Battista, Public Relations, Lattice Biologics Ltd., 16701 N 90th Street, Suite #101, Scottsdale, AZ 85260, 480-563-0800 Office, News@LatticeBiologics.com | www.LatticeBiologics.com
Follow us on Twitter: @LatticeBio